Four Industry Trends that will Shape Medical Affairs in 2023
In 2022, organizations gained ground in patient trust, decentralized clinical trials, virtual tools, and diverse conversations throughout the product development process. So – now what?
The Value and Strategic Implementation of Insights Management
This White Paper provides a foundational understanding of insights management, including the definition and value of insights, processes and technologies for insights management, and key challenges in implementation.
The Digital Transformation of Medical Journal Publishing Episode 3: Open Access from the Publisher’s Perspective
In this our third episode this season, we’ll be discussing how and why medical publishing is changing and where is it going in the future.
ChatGPT is Poised to Disrupt Medical Affairs
With a multibillion dollar investment from Microsoft and already 4 authorship credits on PubMed, ChatGPT is poised to disrupt Medical Affairs.
How Companies Are Using Real-World Evidence for Regulatory Purposes
This presentation looks at different regulatory contexts in which product developers are using RWE.
How Medical Affairs Can Drive Patient-Focused Drug Development
2023 brings increased expectations from the FDA for patient-focused drug development (PFDD). Medical Affairs organizations need to develop new skills to put the patient voice at the center of drug, device, and diagnostic development and evaluation.
Secrets for a Successful Conference Season for Medical Affairs
Congresses are often the best opportunity to connect with HCPs and KOLs. Learn 5 secrets for success.
2023, the year of personalization? Omnichannel principles for Training Strategies
This webinar highlights the continued importance of omnichannel engagement for healthcare practitioners and learners and the need to equip our internal teams appropriately.
Medical Affairs Innovation Olympians Dare to Share for Our Healthcare
Medical Affairs professionals across the globe became first-time Innovation Olympians, responded to a bold challenge, celebrated competition, accelerated innovation together, and shared a memorable experience together.
Using Real-World Evidence for Label Expansions
This virtual presentation focuses on 3 aspects of RWE: What are RWE and Real-World Data (RWD), and how are they different? What are relevant legal and regulatory considerations associated with using RWE for product label expansion? How have applicants successfully used RWE to obtain approval for new drug and medical device indications?